NHERF2 and cancer: Greater variation was detected in the presence of HPV16, so this difference between the control tissue and HPV16+ OPSCCs was significant with a p-value of 0.0013, indicating that the presence of HPV16 E6 in these cancer types reduced the amount of NHERF2.